BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35947307)

  • 21. miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression.
    Wang H; Wang Z; Wang Y; Li X; Yang W; Wei S; Shi C; Qiu J; Ni M; Rao J; Cheng F
    J Cell Mol Med; 2021 Aug; 25(15):7381-7394. PubMed ID: 34272822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis.
    Lu H; Zhang R; Zhang S; Li Y; Liu Y; Xiong Y; Yu X; Lan T; Li X; Wang M; Liu Z; Zhang G; Li J; Chen S
    Int Immunopharmacol; 2023 Nov; 124(Pt B):111002. PubMed ID: 37804655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl
    He C; Shu B; Zhou Y; Zhang R; Yang X
    Life Sci; 2021 Jul; 276():119294. PubMed ID: 33675896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-β1/Smads pathway.
    Zhang R; Wang M; Lu H; Wang J; Han X; Liu Z; Li L; Li M; Tian X; Chen S; Zhang G; Xiong Y; Li J
    Adv Clin Exp Med; 2023 Apr; 32(4):469-479. PubMed ID: 36413180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA FRMD6-AS1/miR-491-5p/USP13 pathway attenuated ferroptosis and contributed to liver fibrosis.
    Li Z; Zou W; Jin X; Wang Y
    Environ Toxicol; 2024 Jun; 39(6):3760-3771. PubMed ID: 38558500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PGE
    Brea R; Motiño O; Francés D; García-Monzón C; Vargas J; Fernández-Velasco M; Boscá L; Casado M; Martín-Sanz P; Agra N
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):325-337. PubMed ID: 29109031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation.
    Gao H; Wang X; Ma H; Lin S; Zhang D; Wu W; Liao Z; Chen M; Ye H; Li Q; Lin M; Li D
    Sci Rep; 2022 Dec; 12(1):21199. PubMed ID: 36482069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA MALAT1 aggravates human retinoblastoma by sponging miR-20b-5p to upregulate STAT3.
    Wang L; Zhang Y; Xin X
    Pathol Res Pract; 2020 Jun; 216(6):152977. PubMed ID: 32336590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p.
    Chen L; Chen R; Velazquez VM; Brigstock DR
    Am J Pathol; 2016 Nov; 186(11):2921-2933. PubMed ID: 27662798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miRNA-150-5p promotes hepatic stellate cell proliferation and sensitizes hepatocyte apoptosis during liver fibrosis.
    Chen W; Yan X; Yang A; Xu A; Huang T; You H
    Epigenomics; 2020 Jan; 12(1):53-67. PubMed ID: 31833387
    [No Abstract]   [Full Text] [Related]  

  • 31. MicroRNA-125a-5p Contributes to Hepatic Stellate Cell Activation through Targeting FIH1.
    Li G; Li J; Li C; Qi H; Dong P; Zheng J; Yu F
    Cell Physiol Biochem; 2016; 38(4):1544-52. PubMed ID: 27074047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells.
    Ju B; Nie Y; Yang X; Wang X; Li F; Wang M; Wang C; Zhang H
    J Cell Mol Med; 2019 Jun; 23(6):3824-3832. PubMed ID: 30945448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL-6 pathway through miR-124.
    Alavifard H; Mazhari S; Meyfour A; Tokhanbigli S; Ghavami S; Zali MR; Aghdaei HA; Hatami B; Baghaei K
    Cell Biol Int; 2023 May; 47(5):969-980. PubMed ID: 36655489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pinostilbene hydrate suppresses hepatic stellate cell activation via inhibition of miR-17-5p-mediated Wnt/β-catenin pathway.
    Zhou G; Li C; Zhan Y; Zhang R; Lv B; Geng W; Zheng J
    Phytomedicine; 2020 Dec; 79():153321. PubMed ID: 32919323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.
    Fernández-Ramos D; Fernández-Tussy P; Lopitz-Otsoa F; Gutiérrez-de-Juan V; Navasa N; Barbier-Torres L; Zubiete-Franco I; Simón J; Fernández AF; Arbelaiz A; Aransay AM; Lavín JL; Beraza N; Perugorria MJ; Banales JM; Villa E; Fraga MF; Anguita J; Avila MA; Berasain C; Iruzibieta P; Crespo J; Lu SC; Varela-Rey M; Mato JM; Delgado TC; Martínez-Chantar ML
    Cell Death Dis; 2018 Sep; 9(10):958. PubMed ID: 30237481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
    Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
    J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
    Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
    Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.
    Wang J; Chu ES; Chen HY; Man K; Go MY; Huang XR; Lan HY; Sung JJ; Yu J
    Oncotarget; 2015 Mar; 6(9):7325-38. PubMed ID: 25356754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
    Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis.
    Feng Y; Li Y; Xu M; Meng H; Dai C; Yao Z; Lin N
    Stem Cell Res Ther; 2022 Jul; 13(1):375. PubMed ID: 35902883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.